Gardasil Winners

By

Sally Fallon and Mary Enig PhD.
Weston A. Price Foundation

Vaccine pushers have pulled out all the stops to promote Gardasil, intensely marketing the new vaccine to the parents of young girls as young as age nine. The vaccine is said to protect against two strains of Human Papilloma Virus (HPV) which, according to the scare-mongers, cause about 70 percent of all cervical cancers.

Cervical cancer is rare, contributing to four deaths per 100,000 in the US, with less than 6 percent of these in women under 35 years of age. And causation by HPV has not been proven--in a controlled study of age-matched women, 67 percent of those with cervical cancer and 43 percent of those without were found to be HPV-positive and these cancers were observed on average only 20-25 years after infection. Apologists insist that it is perfectly safe to vaccinate millions of girls against the remote and unproven possibility of HPV-induced cervical cancer, citing clinical trials in which those receiving a placebo and those receiving the vaccine had a similar number of adverse events.

What trusting parents don't realize is that the placebo used in the trials was not a non-reactive saline solution, but contained reactive aluminum. This is the old "equivalent" placebo trick, which researchers use without the slightest twinge of conscience to "prove" the safety of poisonous additives like MSG and aspartame. The Gardasil vaccine contains 225 mcg of aluminum per jab.

Vaccine aluminum adjuvants can allow aluminum to enter the brain, as well as cause inflammation at the injection site leading to fatigue and chronic joint and muscle pain. The media have not seen fit to report on the shocking fact that around 60 (!) percent of those participating in the trials--both those who got the vaccine and those who got the "placebo"--suffered side effects such as headache, fever, nausea, dizziness, vomiting, and diarrhea. The side effects were more serious in the group receiving Gardasil, and included asthma, bronchospasm, arthritis and--most ironically--pelvic inflammatory disease.

The winners, of course, will not be the poor nine-year-olds subjected to vaccination, but the drug company Merck, which expects sales of at least two billion dollars by lobbying for their vaccine to be required for school admittance (www.ahrp.org/cms/content/view/263/28/)